TTFields Combo Shows Meaningful Benefits in Pancreatic Adenocarcinoma
Written by
Cancer Network
Published
0
comments
0
min
Data from the PANOVA-3 trial may support the concomitant use of TTFields plus standard of care in solid tumors across different therapeutic settings.